Norinchukin Bank The Increases Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Norinchukin Bank The increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 9.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,935 shares of the medical device company’s stock after purchasing an additional 766 shares during the quarter. Norinchukin Bank The’s holdings in Cooper Companies were worth $821,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Fulton Bank N.A. lifted its stake in shares of Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares during the last quarter. Covestor Ltd boosted its stake in shares of Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock valued at $42,000 after purchasing an additional 120 shares during the period. Torray Investment Partners LLC grew its holdings in shares of Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after purchasing an additional 132 shares during the last quarter. Mather Group LLC. grew its holdings in shares of Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after purchasing an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after buying an additional 136 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup lowered their price target on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Robert W. Baird cut their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Piper Sandler restated an “overweight” rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Finally, JPMorgan Chase & Co. dropped their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Price Performance

COO opened at $78.70 on Tuesday. The Cooper Companies, Inc. has a 12-month low of $69.81 and a 12-month high of $112.38. The company has a market cap of $15.74 billion, a price-to-earnings ratio of 40.36, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $82.79 and a two-hundred day simple moving average of $93.29.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.